Page last updated: 2024-10-31

clorgyline and Left Ventricular Dysfunction

clorgyline has been researched along with Left Ventricular Dysfunction in 2 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Umbarkar, P1
Singh, S1
Arkat, S1
Bodhankar, SL1
Lohidasan, S1
Sitasawad, SL1
Kaludercic, N1
Takimoto, E1
Nagayama, T1
Feng, N1
Lai, EW1
Bedja, D1
Chen, K1
Gabrielson, KL1
Blakely, RD1
Shih, JC1
Pacak, K1
Kass, DA1
Di Lisa, F1
Paolocci, N1

Other Studies

2 other studies available for clorgyline and Left Ventricular Dysfunction

ArticleYear
Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Free radical biology & medicine, 2015, Volume: 87

    Topics: Animals; Antioxidants; Apoptosis; Clorgyline; Diabetes Mellitus, Experimental; Diabetic Cardiomyopat

2015
Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.
    Circulation research, 2010, Jan-08, Volume: 106, Issue:1

    Topics: Animals; Blood Pressure; Cardiomegaly; Clorgyline; Heart Failure; Heart Ventricles; Hydrogen Peroxid

2010